Global Market for Pulmonary Drug Delivery Systems to Reach $43.9 Billion in 2018; Dry Powder Inhalers (DPIs) Segment Moving At 12.5% CAGR

June 24, 2014

Wellesley, Mass., June 24th, 2014 – BCC Research ( reveals in its new report, PULMONARY DRUG DELIVERY SYSTEMS: TECHNOLOGIES AND GLOBAL MARKETS, the global market for pulmonary drug delivery systems is expected to grow to $43.9 billion by 2018 with a compound annual growth rate (CAGR) of 6.2% from 2013 to 2018. The dry powder inhalers category is the fastest moving segment in this market, growing at a significant five-year CAGR of 12.5%.

The recent trends in the formulating sector show increased sales of dry powder inhalers (DPIs). It currently represents 25% and is progressing to the frontline at a steady rate. Its global market is estimated to outgrow the previously held dominant segment of metered dose inhalers (MDIs) by 2018. The U.S.A. and Europe together are currently the forerunners in the pulmonary inhalables segment.

Rising cases of respiratory disorders, new innovations in pharmaceutical formulations and combinations, emergence of better sophisticated inhaler device designs and consumer desire for noninvasive methods have led to the growth of drug delivery systems in the last few years. 

“Pulmonary drug delivery technologies are focused on developing simple, easy-to-use and cost-effective devices,” says BCC Research analyst, Usha Nagavarapu. “The global market for dry powder inhalers is expected to rise between 2013 through 2018 due to better device engineering and powder formulations.”

PULMONARY DRUG DELIVERY SYSTEMS: TECHNOLOGIES AND GLOBAL MARKETS provides an overview of the present and future global market trends for pulmonary drug delivery systems with data from 2012 and 2013, and CAGRs projections through 2018. A separate section of the report discusses the examination of devices currently being used for drug delivery to the lungs, new developments, spending trends, and revenue prospects for these technologies. It also includes information on product innovations and recent strategic industry activities of major players across different product categories. In addition, this study covers relevant profiles of leading companies in the industry.

To Contact us, click here  help

Source: BCC Research

Editors and reporters who wish to speak with the analyst should contact Steven Cumming at

Pulmonary Drug Delivery Systems: Technologies and Global Markets( HLC094B )
Publish Date: May 2014    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email or visit to request access to our library of market research.